Advertisement
Advertisement
TNDM
Tandem Diabetes Care, Inc.
19.42
USDSponsored
-0.45
-2.26%
May 05, 16:00 UTC -4
Closed
After-Market
19.39
-0.03
-0.13%
TNDM Earnings Reports
Positive Surprise Ratio
TNDM beat 21 of 41 last estimates.
51%
Next Report
In 2 Days
Date of Next Report
May 07, 2026
Estimate for Q1 26 (Revenue/ EPS)
$245.24M
/-$0.45
Implied change from Q4 25 (Revenue/ EPS)
-15.55%
/+4400.00%
Implied change from Q1 25 (Revenue/ EPS)
+4.61%
/-31.82%
Tandem Diabetes Care, Inc. earnings per share and revenue
On Feb 19, 2026, TNDM reported earnings of -0.01 USD per share (EPS) for Q4 25, beating the estimate of -0.08 USD, resulting in a 88.08% surprise. Revenue reached 290.38 million, compared to an expected 282.57 million, with a 2.77% difference. The market reacted with a +32.67% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 22 analysts forecast an EPS of -0.45 USD, with revenue projected to reach 245.24 million USD, implying an increase of 4400.00% EPS, and decrease of -15.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alphatec Holdings, Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
iRadimed Corporation
Report Date
May 01, 2026 For Q1 26
Estimate
$0.45
Actual
$0.49
Surprise
+7.95%
Tactile Systems Technology, Inc.
Report Date
May 04, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.08
Surprise
+16.58%
Orthofix Medical Inc. Common Stock (DE)
Report Date
May 05, 2026 For Q1 26
Estimate
-$0.69
Actual
-$0.12
Surprise
+82.70%
Neuronetics, Inc. Common Stock
Report Date
May 05, 2026 For Q1 26
Estimate
-$0.17
Actual
-$0.16
Surprise
+9.50%
InspireMD, Inc.
Report Date
May 04, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.16
Surprise
+12.85%
Idexx Laboratories Inc
Report Date
May 05, 2026 For Q1 26
Estimate
$3.46
Actual
$3.47
Surprise
+0.10%
Waters Corp
Report Date
May 05, 2026 For Q1 26
Estimate
$2.35
Actual
$2.70
Surprise
+14.42%
IQVIA Holdings Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$2.84
Actual
$2.90
Surprise
+1.92%
TransMedics Group, Inc. Common Stock
Report Date
May 05, 2026 For Q1 26
Estimate
$0.62
Actual
$0.30
Surprise
-52.00%
FAQ
What were Tandem Diabetes Care, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Tandem Diabetes Care, Inc. reported EPS of -$0.01, beating estimates by 88.08%, and revenue of $290.38M, 2.77% above expectations.
How did the market react to Tandem Diabetes Care, Inc.'s Q4 2025 earnings?
The stock price moved up 32.67%, changed from $18.52 before the earnings release to $24.57 the day after.
When is Tandem Diabetes Care, Inc. expected to report next?
The next earning report is scheduled for May 07, 2026.
What are the forecasts for Tandem Diabetes Care, Inc.'s next earnings report?
Based on 22
analysts, Tandem Diabetes Care, Inc. is expected to report EPS of -$0.45 and revenue of $245.24M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement